In-depth trading ideas

Discover detailed market analysis from traders. See how others approach this instrument, compare different strategies, and discover perspectives that can shape your own view.

PR RELEASE valix?Noticed some trends in the PR releases, wondering if they will follow

VXL.V -- High risk/high reward Coronavirus vaccine developer VXL is the volume leader on TSX-V today on the news of Coronavirus vaccine patent application. +21.74% so far. Likely held down by warrant sellers but could be a serious runner once they are out. $12M mkt cap is cheap compared to other biomed stocks that ran on Coronavirus related news. Very decent float at 89M shares.

by agstockpicks